Ignite Creation Date:
2024-05-06 @ 2:25 PM
Last Modification Date:
2024-10-26 @ 1:30 PM
Study NCT ID:
NCT04311060
Status:
NOT_YET_RECRUITING
Last Update Posted:
2020-03-17
First Post:
2020-03-13
Brief Title:
Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia a Prospective Multicentric Study
Sponsor:
Mexican Agrupation for Hematology Study
Organization:
Mexican Agrupation for Hematology Study
Study Overview
Official Title:
Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia a Prospective Multicenter Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2020-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Newly diagnosed adults patients with Acute Myeloid Leukemia will be assessed as traditionally by the treating institution using classic clinical demographic and cytogenetic variables Complementary molecular tests will be performed in the patients included in the study using PCR to detect classic CBF Core Binding Factor rearrangements CBFB-MYH11 inv16p13q22 isoforms A E and D AML-ETO RUNX1-RUNX1T1 t821q22q22 NGS Next Generation Sequencing to detect mutations in FLT3-ITD and TKD NPM1 CEBPA RUNX1 TP53 ASXL1 IDH1 IDH2 and KIT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None